US Broker Ratings

Immatics N.V. (IMTX) Stock Analysis: A Promising Biotech with 158% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Germany, has been gaining attention in the investment community for its innovative approach to cancer treatment. The company specializes in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Diagnostic Innovations Amidst Market Volatility

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of approximately $578.74 million, the..

Precigen, Inc. (PGEN) Stock Analysis: Unraveling an 81% Upside Potential in Biotechnology

Investors keen on the biotechnology sector should pay close attention to Precigen, Inc. (NASDAQ: PGEN), a discovery and clinical-stage biopharmaceutical company with a market capitalization of $1.36 billion. Specializing in..

Bicycle Therapeutics (BCYC) Stock Analysis: Unpacking a 237.7% Potential Upside in Biotech

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, has captured investor attention with a staggering potential upside of 237.7%. This UK-based clinical-stage pharmaceutical company is at..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Remarkable 244.58% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology industry with a compelling investment narrative, particularly for those following the healthcare sector. With a market capitalization of $449.56 million,..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 23% Upside Potential

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, operates as a comprehensive healthcare solutions provider, catering to a broad array of medical distribution needs. With its..

CareDx, Inc. (CDNA) Stock Analysis: Unlocking a Potential 66% Upside in the Healthcare Sector

CareDx, Inc. (CDNA) is a prominent player in the healthcare sector, focusing on the development and commercialization of diagnostic solutions for transplant patients. With a market capitalization of $697.8 million,..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 230% Potential Upside in Biotech Innovations

Investors in the biotechnology sector are keeping a keen eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotech firm that’s making waves with its promising pipeline of gene therapies. The..

Auna SA (AUNA) Stock Analysis: Unveiling a 92% Potential Upside for Investors

Auna SA (AUNA), a key player in the healthcare sector, operates across the vibrant landscapes of Mexico, Peru, and Colombia. Specializing in medical care facilities, the company presents an intriguing..

Mind Medicine (MNMD) Stock Analysis: Exploring a 155.62% Potential Upside in the Biotech Sector

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers an intriguing proposition for investors with a high-risk tolerance, given the company’s focus on developing novel treatments for brain health disorders. This clinical..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 52.99% Upside Potential Beckons Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a notable player in the healthcare sector, primarily operates in the medical devices industry. With a market capitalization of $582.15 million, the company is strategically..

uniQure N.V. (QURE) Stock Analysis: Exploring a 128.60% Potential Upside in the Biotech Sector

With a market capitalization of $892.14 million, uniQure N.V. (QURE) presents a compelling case for investors looking to tap into the biotechnology sector’s potential. Headquartered in Amsterdam, Netherlands, uniQure is..

Delcath Systems, Inc. (DCTH) Stock Analysis: A 123% Potential Upside in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention from investors in the healthcare sector, particularly within the niche of medical devices. The company, headquartered in New York, is making..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating the Cannabis Sector with a 24.50 Forward P/E

Tilray Brands, Inc. (NASDAQ: TLRY) stands as a prominent player within the healthcare sector, specifically in the niche of drug manufacturers focusing on specialty and generic products. Based in Canada,..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating the Healthcare Sector Amid Revenue Challenges

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, presents a compelling case for careful consideration by investors. Despite its market cap of $490.84..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Forward P/E of 13.19

Avanos Medical, Inc. (NYSE: AVNS), a key player in the healthcare sector, specializes in medical devices that address critical needs in digestive health and non-opioid pain management. With a market..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring 134% Potential Upside in Biotech Innovation

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a pioneering entity in the biotechnology sector, offers a compelling narrative for investors intrigued by the promise of gene therapy for rare diseases. This late-stage..

Arvinas, Inc. (ARVN): Investor Outlook on a Biotech Stock with 137.69% Potential Upside

Arvinas, Inc. (NASDAQ: ARVN), a prominent player in the biotechnology sector, is capturing the attention of investors with its cutting-edge approach to drug development and a striking potential upside of..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Exploring a Promising 142.70% Upside

ATAI Life Sciences N.V. (NASDAQ: ATAI) is generating significant buzz in the biotechnology sector, offering a compelling opportunity for investors intrigued by the convergence of mental health treatment innovation and..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 14.94% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a prominent player in the medical instruments and supplies industry, is carving its niche in the healthcare sector with a focus on diabetes care solutions. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds